Thomas Defay
Impact in
-
- Genomics and Rare Diseases
- Genetics and Neurodevelopmental Disorders
- Virus-based gene therapy research
-
- Metabolism and Genetic Disorders
Papers in
-
- CRISPR and Genetic Engineering 2
- Amyloidosis: Diagnosis, Treatment, Outcomes 1
- Genetics 3
- Genomics and Rare Diseases 3
- Neurogenetic and Muscular Disorders Research 1
- Genetics and Neurodevelopmental Disorders 1
- Genomic variations and chromosomal abnormalities 1
- Virus-based gene therapy research 1
- Co-authors
- Jerry Vockley (2 shared papers)Timothy W. Yu (2 shared papers)Amy L. McGuire (1 shared paper)R. Rodney Howell (1 shared paper)Jennifer L. Cohen (1 shared paper)Amy Brower (1 shared paper)Aaron J. Goldenberg (1 shared paper)Mark W. Skinner (1 shared paper)
- Journals
- American Journal of Medical Genetics Part C Seminars in Medical Genetics (3 papers)Blood (1 paper)
- Partner nations
- United StatesNetherlandsCanada
In The Last Decade
Thomas Defay
3 papers receiving 20 citations
Peers
Comparison fields: 5 of 16
- Genetics 18
- Clinical Biochemistry 4
- Genetics 2
- Molecular Biology 10
- Cancer Research 2
Countries citing papers authored by Thomas Defay
This map shows the geographic impact of Thomas Defay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Defay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Defay more than expected).
Fields of papers citing papers by Thomas Defay
This network shows the impact of papers produced by Thomas Defay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Defay. The network helps show where Thomas Defay may publish in the future.
Co-authors
The 20 scholars most cited alongside Thomas Defay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 10 | |
| 2 | 2023 | 7 | |
| 3 | 2022 | 5 | |
| 4 | 2022 | 0 |
About Thomas Defay
Thomas Defay is a scholar working on Molecular Biology, Genetics, Genetics, Infectious Diseases and Organic Chemistry, having authored 4 papers that have together received 22 indexed citations. Recurring topics across this work include Genomics and Rare Diseases (3 papers), CRISPR and Genetic Engineering (2 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (1 paper), Neurogenetic and Muscular Disorders Research (1 paper), Genetics and Neurodevelopmental Disorders (1 paper), Genomic variations and chromosomal abnormalities (1 paper) and Virus-based gene therapy research (1 paper). The work is most often cited by research in Genetics (18 citations), Clinical Biochemistry (4 citations), Genetics (2 citations), Molecular Biology (10 citations) and Cancer Research (2 citations). Thomas Defay has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Jerry Vockley, Timothy W. Yu, Amy L. McGuire, R. Rodney Howell, Jennifer L. Cohen, Amy Brower, Aaron J. Goldenberg, Mark W. Skinner, Lex M. Cowsert and Melissa Wasserstein. Their work appears in journals such as American Journal of Medical Genetics Part C Seminars in Medical Genetics and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.